|Bid||10.57 x 900|
|Ask||10.61 x 900|
|Day's range||10.43 - 11.00|
|52-week range||8.23 - 19.50|
|Beta (5Y monthly)||1.79|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Earlier today, NANO-X IMAGING, LTD. released its financial results for the quarter ended September 30, 2022. Erez Meltzer, chief executive officer; and Ran Daniel, chief financial officer, will host this morning's call.
Taking the occasional loss comes part and parcel with investing on the stock market. And unfortunately for Nano-X...
Shares of Nano-X Imaging (NASDAQ: NNOX), commonly called Nanox, soared on Wednesday after it revealed it's taken the next step toward commercializing its flagship medical device. As of 12:20 p.m. ET, Nanox stock was up 21%. Nanox had its initial public offering (IPO) in 2020, promising to disrupt the X-ray industry with its digital-3D imaging machines that will be cheaper for doctors to use.